Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Kaiser Permanente study finds postmenopausal women with cancer report a greater decline in physical function than women who have not had cancer.
Kaiser Permanente "Be-Well" study finds long-term history of smoking cigarettes increases the risk of a cancer recurrence in people who have been treated for bladder cancer.
Two new papers detail how Kaiser Permanente oncology care teams restructured processes to enhance care for patients with breast and lung cancer.
A new Kaiser Permanente study finds promise in ‘food as medicine’ delivery for some — but not all — patients with chronic conditions.
Caan joins a team of researchers who have received a $25 million Cancer Grand Challenges award to tackle the challenge of cachexia — a debilitating wasting condition people often experience in the later stages of their cancer.
Kaiser Permanente clinical research finds patients who have a site biopsied after a suspected cancer is biopsied are not more likely to develop a second cancer.
A new Kaiser Permanente study shows that having radiologists use standardized terms and hashtags to describe what they see creates a clearer path for physician follow-up that can lead to earlier detection of pancreatic cancer.
Study led by Kaiser Permanente research scientist Lawrence H. Kushi, ScD, will help advance precision cancer care.
Kaiser Permanente research scientists Lawrence H. Kushi, ScD, and Bette Caan, DrPH, contribute to new American Cancer Society survivorship guideline.
KP Research Radio explores how oncologists used phone and video appointments to expand care options for cancer patients during the COVID-19 pandemic.